| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/30/2005 | US20050142601 Nucleic acids encoding an enediyne polyketide synthase complex |
| 06/30/2005 | US20050142587 Mammalian proteins designated Dendritic Cell Specific Transmembrane Protein (DC-STAMP) and DNAX Surface Protein (DSP-1) and their biological activities; useful in regulation, activation, development, differentiation, and function of various cell types, including hematopoietic cells |
| 06/30/2005 | US20050142566 Sperm-specific cation channel, catSper2, and uses therefor |
| 06/30/2005 | US20050142562 High throughput generation and screening of fully human antibody repertoire in yeast |
| 06/30/2005 | US20050142561 Intracellular signaling pathways in diabetic subjects |
| 06/30/2005 | US20050142557 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | US20050142552 Susceptibility locus for schizophrenia |
| 06/30/2005 | US20050142541 Antibodies for oncogenic strains of HPV and methods of their use |
| 06/30/2005 | US20050142539 Targeted ligands |
| 06/30/2005 | US20050142146 Vaccine; against Chlamydia pneumonia; therapy, prevention of infections, |
| 06/30/2005 | US20050142145 Derivatives of choline binding proteins for vaccines |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142141 Delivery of enzymes to the brain |
| 06/30/2005 | US20050142140 Immunoadhesin comprising a glycoprotein VI domain |
| 06/30/2005 | US20050142139 and a histidine buffer; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142137 Human monoclonal antibodies against secretory leukocyte protease inhibitor (SLPI); host cells, expression vectors; anticancer agents |
| 06/30/2005 | US20050142136 Anti-interleukin 8 therapy for tumor osteolysis |
| 06/30/2005 | US20050142135 Agents and methods for modulating interactions between gonadotropin hormones and receptors |
| 06/30/2005 | US20050142134 LFA-1 alpha subunit antibodies and methods of use |
| 06/30/2005 | US20050142133 Optimized proteins that target the epidermal growth factor receptor |
| 06/30/2005 | US20050142132 Prevention and treatment of amyloidogenic disease |
| 06/30/2005 | US20050142131 use treating diseases associated with amyloid beta (A beta), such as Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy; host cells |
| 06/30/2005 | US20050142120 Cells expressing anti-Fc receptor binding components |
| 06/30/2005 | US20050142117 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 06/30/2005 | US20050142108 Methods of modulating cytokine activity; related reagents |
| 06/30/2005 | US20050142062 Novel method of diagnosing and treating gliomas |
| 06/30/2005 | DE10355904A1 Feste Formen von anti-EGFR-Antikörpern Solid forms of anti-EGFR antibodies |
| 06/30/2005 | CA2550893A1 Molecular signature of the pten tumor suppressor |
| 06/30/2005 | CA2550155A1 Hla-dr-specific antibodies, compositions and methods |
| 06/30/2005 | CA2550108A1 Active immunization against clostridium difficile disease |
| 06/30/2005 | CA2549800A1 Novel anti-dc-sign antibodies |
| 06/30/2005 | CA2549000A1 Method for treating neurological disorders |
| 06/30/2005 | CA2548792A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/30/2005 | CA2548769A1 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | CA2548502A1 Methods and compositions relating to ccr5 antagonist, ifn-.gamma. and il-13 induced inflammation |
| 06/30/2005 | CA2548338A1 Ip-10 antibodies and their uses |
| 06/30/2005 | CA2548282A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 06/30/2005 | CA2547060A1 Pharmaceutical preparation comprising an antibody against the egf receptor |
| 06/30/2005 | CA2546054A1 Interferon alpha antibodies and their uses |
| 06/29/2005 | EP1548114A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 06/29/2005 | EP1548028A1 Substituted type peptides of wt1 |
| 06/29/2005 | EP1547613A1 Medication and method for treating pathological syndrome |
| 06/29/2005 | EP1547612A1 Medicinal agent and method for curing erectile dysfunction |
| 06/29/2005 | EP1547611A1 Medicinal agent and method for curing prostate diseases |
| 06/29/2005 | EP1547451A2 Cell adhesion resisting surfaces |
| 06/29/2005 | EP1546734A1 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 06/29/2005 | EP1546716A2 Pregnancy detection |
| 06/29/2005 | EP1546712A2 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 06/29/2005 | EP1546415A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 06/29/2005 | EP1546360A2 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 06/29/2005 | EP1546358A2 Anti-il-tif antibodies and methods of using in inflammation |
| 06/29/2005 | EP1546346A2 Embryonic stem cell markers and uses thereof |
| 06/29/2005 | EP1546341A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 06/29/2005 | EP1546314A1 Bhyd gene |
| 06/29/2005 | EP1546205A1 Methods for regulating cancer |
| 06/29/2005 | EP1546204A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/29/2005 | EP1546203A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 06/29/2005 | EP1546196A1 Marker for cancer |
| 06/29/2005 | EP1546182A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/29/2005 | EP1545617A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 06/29/2005 | EP1545616A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 06/29/2005 | EP1545615A2 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
| 06/29/2005 | EP1545614A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/29/2005 | EP1545613A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 06/29/2005 | EP1545612A1 Modulation of mesenchymal cells via iga-receptors |
| 06/29/2005 | EP1545611A1 Method of treatment of asthma using antibodies to complement component c5 |
| 06/29/2005 | EP1545610A2 Epitope sequences |
| 06/29/2005 | EP1545609A2 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 06/29/2005 | EP1545608A2 Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| 06/29/2005 | EP1545607A1 Allergy vaccines |
| 06/29/2005 | EP1545606A1 Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies |
| 06/29/2005 | EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2005 | EP1545601A2 Lfa-1 alpha subunit antibodies and methods of use |
| 06/29/2005 | EP1545599A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 06/29/2005 | EP1545597A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 06/29/2005 | EP1545596A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 06/29/2005 | EP1545591A2 Therapeutic use for lp229, in particular for wound healing |
| 06/29/2005 | EP1545588A2 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 06/29/2005 | EP1545582A2 Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof |
| 06/29/2005 | EP1545578A2 Compositions and methods for treating cardiovascular disease |
| 06/29/2005 | EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 06/29/2005 | EP1545430A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2005 | EP1173619B1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 06/29/2005 | EP1119625B1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/29/2005 | EP1037990B8 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/29/2005 | EP1015037B1 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
| 06/29/2005 | EP0954326B1 A process for viral inactivation of lyophilized blood proteins |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633448A Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 06/29/2005 | CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor |
| 06/29/2005 | CN1631899A Use of DLP in Pre-mRNA splicing and cell cycle control |
| 06/29/2005 | CN1208344C Novel human cell endocytic regulatory protein, its coding sequence and use |
| 06/28/2005 | US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 06/28/2005 | US6911535 Biomolecule/polymer conjugates |
| 06/28/2005 | US6911534 Method for determination of water treatment polymers |
| 06/28/2005 | US6911532 Vertebrate apoptosis gene: compositions and methods |
| 06/28/2005 | US6911527 HIV related peptides |
| 06/28/2005 | US6911429 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus |
| 06/28/2005 | US6911321 Non-human primate Fc receptors and methods of use |